Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Th1 Response to Influenza: Aging and Vaccine Efficacy

Authors not listed

National Institute of Allergy and Infectious Diseases (NIAID) · 2006

Abstract

This research study is being done because influenza (flu) affects many people each year throughout the world. The elderly and those with chronic health problems are at greater risk for complications from the flu. The purpose of this research study is to evaluate vaccination strategies in the elderly and others receiving the influenza vaccination in order to increase protection. All subjects will receive the flu vaccine as an injection in the muscle of the upper arm. Participants may receive a booster \[an extra dose of vaccine or placebo (inactive substance)\] shot. Study participants will include healthy adult volunteers, ages 21-40, 60-89, or 90 years and older. Subjects will be involved in study related procedures for 6 months.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
Anonymous. (2006). Th1 Response to Influenza: Aging and Vaccine Efficacy. <em>National Institute of Allergy and Infectious Diseases (NIAID)</em>. https://clinicaltrials.gov/study/NCT00396305
Vancouver
Anonymous. Th1 Response to Influenza: Aging and Vaccine Efficacy. National Institute of Allergy and Infectious Diseases (NIAID). 2006.
BibTeX
@misc{anon2006ThResp, title = {Th1 Response to Influenza: Aging and Vaccine Efficacy}, author = {Anonymous}, journal = {National Institute of Allergy and Infectious Diseases (NIAID)}, year = {2006}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings